Jon Isaacsohn
Plus aucun poste en cours
Historique de carrière de Jon Isaacsohn
Anciens postes connus de Jon Isaacsohn
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| CINCOR PHARMA, INC. | Directeur/Membre du Conseil | 06/07/2021 | 01/11/2021 |
| Directeur Général | - | 06/07/2021 | |
| Directeur Technique/Scientifique/R&D | 06/07/2021 | 01/11/2021 | |
| Fondateur | - | 01/11/2021 |
Statistiques
Internationale
| Etats-Unis | 2 |
Opérationnelle
| Director/Board Member | 1 |
| Chief Executive Officer | 1 |
| Chief Tech/Sci/R&D Officer | 1 |
Sectorielle
| Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 1 |
|---|---|
CinCor Pharma, Inc.
 CinCor Pharma, Inc. Pharmaceuticals: MajorHealth Technology CinCor Pharma, Inc. operates as a clinical-stage biopharmaceutical company focused on developing its clinical candidate, CIN-107, for the treatment of hypertension and other cardio-renal diseases. The firm is developing CIN-107 for the treatment of multiple diseases where aldosterone plays a significant role in disease pathophysiology, including hypertension and primary aldosteronism, as well as its utility in ameliorating complications of chronic kidney disease. The company was founded by Jon Isaacsohn and Catherine Pearce on March 28, 2018 and is headquartered in Waltham, MA. | Health Technology |
- Bourse
- Insiders
- Jon Isaacsohn
- Expérience
